Ladder Bio Inc.
United States
- Blue Bell, PA
- 13/11/2025
- Seed
- $5,500,000
Ladder Bio (formerly ThirdLaw Molecular) has pioneered the development of Spiroligomer™ molecules and is developing this innovative, patent-protected, therapeutic modality into a new class of more targeted medicines. The mission of Ladder Bio is to create a revolutionary category of molecules that transform how diseases are diagnosed and treated – more safely and effectively.
- Industry Biotechnology Research
- Website https://ladderbio.com/
- LinkedIn https://www.linkedin.com/company/thirdlaw-llc/
Related People
Eric HeilFounder
United States -
Doylestown, Pennsylvania
With nearly 20 years of experience in healthcare venture capital and entrepreneurship, I am a Managing Partner at Medical Excellence Capital (MEC), an early-stage life science venture fund that leverages a global network of medical experts, family offices, and academic institutions to invest in innovative and impactful biotech and precision health technologies.
I have personally co-founded, launched, and led several successful healthcare companies, including RightCare Solutions, a digital health company that was acquired by naviHealth, and Upward Health, a tech-enabled care delivery service for complex patients. Cofounded ProJenX, an neurogenerative company, and helped launch Ladder Bio. I have also served as a board member, board observer, advisor, and executive for multiple venture-backed companies, such as Ladder Bio, ProJenX, Nobias Therapeutics, GC Therapeutics, and others.
I am passionate about improving the U.S. healthcare system collaboratively with innovative life science technologies, value-oriented care delivery strategies, and evidence-based solutions that make a positive difference for patients. I am driven by the desire to positively impact patients and to be part of a team-based culture committed to collaborating with passionate and dedicated innovators, financiers, and strategic partners. I am also a former adjunct professor and co-instructor of healthcare entrepreneurship at the Wharton School, where I earned my MBA, and I also hold a BSE in Systems Engineering and Healthcare Systems from the University of Pennsylvania.
A dedicated husband/father of a blended family with five great kids!
Trillium Renewable Chemicals | $13,000,000 | (May 7, 2026)
RadixArk | $100,000,000 | (May 7, 2026)
Astrada | $3,800,000 | (May 7, 2026)
Cytospire Therapeutics Ltd | $82,984,705 | (May 7, 2026)
QuantWare | $178,775,560 | (May 7, 2026)
MOSH | $13,000,000 | (May 7, 2026)
InstaSwitch | $4,700,000 | (May 7, 2026)
Smartness | $55,270,590 | (May 7, 2026)
Scout Space | $18,000,000 | (May 7, 2026)
Altara | $7,000,000 | (May 7, 2026)
District | $14,700,000 | (May 7, 2026)